Birchview Capital as of Sept. 30, 2021
Portfolio Holdings for Birchview Capital
Birchview Capital holds 64 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 32.1 | $47M | 796k | 59.17 | |
| Accelr8 Technology | 8.9 | $13M | 2.3M | 5.81 | |
| Biodesix (BDSX) | 6.2 | $9.1M | 1.1M | 8.22 | |
| Quidel Corporation | 5.7 | $8.4M | 60k | 141.14 | |
| Neurocrine Biosciences (NBIX) | 5.2 | $7.7M | 80k | 95.91 | |
| Foghorn Therapeutics (FHTX) | 3.0 | $4.4M | 314k | 13.93 | |
| Biogen Idec (BIIB) | 2.4 | $3.6M | 13k | 283.02 | |
| Albireo Pharma | 2.4 | $3.5M | 113k | 31.20 | |
| United Therapeutics Corporation (UTHR) | 2.3 | $3.3M | 18k | 184.56 | |
| ACADIA Pharmaceuticals (ACAD) | 2.3 | $3.3M | 199k | 16.61 | |
| Prothena Corp SHS (PRTA) | 2.0 | $2.9M | 40k | 71.24 | |
| Masimo Corporation (MASI) | 1.5 | $2.2M | 8.0k | 270.75 | |
| Acceleron Pharma | 1.3 | $1.8M | 11k | 172.13 | |
| Continental Resources | 1.2 | $1.8M | 39k | 46.14 | |
| Harrow Health (HROW) | 1.1 | $1.6M | 180k | 9.09 | |
| Bluebird Bio (BLUE) | 1.1 | $1.6M | 84k | 19.11 | |
| Alkermes SHS (ALKS) | 1.0 | $1.5M | 50k | 30.84 | |
| Amarin Corp Spons Adr New (AMRN) | 1.0 | $1.5M | 300k | 5.10 | |
| Karyopharm Therapeutics (KPTI) | 1.0 | $1.4M | 246k | 5.82 | |
| Biohaven Pharmaceutical Holding | 0.9 | $1.4M | 10k | 138.90 | |
| Vanda Pharmaceuticals (VNDA) | 0.9 | $1.4M | 80k | 17.14 | |
| Equitrans Midstream Corp (ETRN) | 0.9 | $1.3M | 133k | 10.14 | |
| Arena Pharmaceuticals | 0.9 | $1.3M | 22k | 59.55 | |
| Nektar Therapeutics (NKTR) | 0.9 | $1.3M | 72k | 17.96 | |
| Arvinas Ord (ARVN) | 0.8 | $1.2M | 15k | 82.20 | |
| Encana Corporation (OVV) | 0.8 | $1.1M | 34k | 32.87 | |
| ImmunoGen | 0.7 | $1.1M | 190k | 5.67 | |
| Cullinan Oncology (CGEM) | 0.7 | $1.0M | 45k | 22.57 | |
| Corcept Therapeutics Incorporated (CORT) | 0.7 | $984k | 50k | 19.68 | |
| Cytokinetics (CYTK) | 0.6 | $894k | 25k | 35.76 | |
| Progyny (PGNY) | 0.6 | $840k | 15k | 56.00 | |
| Soleno Therapeutics | 0.6 | $811k | 877k | 0.92 | |
| Contrafect | 0.6 | $810k | 200k | 4.05 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $698k | 40k | 17.45 | |
| Protagonist Therapeutics (PTGX) | 0.5 | $673k | 38k | 17.71 | |
| Pioneer Natural Resources | 0.4 | $633k | 3.8k | 166.58 | |
| Inari Medical Ord (NARI) | 0.4 | $568k | 7.0k | 81.14 | |
| G1 Therapeutics | 0.4 | $537k | 40k | 13.43 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.4 | $533k | 8.0k | 66.62 | |
| Angion Biomedica Corp | 0.4 | $531k | 54k | 9.76 | |
| Turning Point Therapeutics I | 0.4 | $531k | 8.0k | 66.38 | |
| Gossamer Bio (GOSS) | 0.3 | $503k | 40k | 12.57 | |
| Tg Therapeutics (TGTX) | 0.3 | $499k | 15k | 33.27 | |
| Chemocentryx | 0.3 | $428k | 25k | 17.12 | |
| Progenity | 0.3 | $410k | 270k | 1.52 | |
| Xencor (XNCR) | 0.3 | $402k | 12k | 32.68 | |
| Apellis Pharmaceuticals (APLS) | 0.3 | $396k | 12k | 33.00 | |
| Stoke Therapeutics (STOK) | 0.3 | $382k | 15k | 25.47 | |
| Amicus Therapeutics (FOLD) | 0.2 | $363k | 38k | 9.55 | |
| Aziyo Biologics (ELUT) | 0.2 | $348k | 50k | 6.96 | |
| Kiniksa Pharmaceuticals | 0.2 | $342k | 30k | 11.40 | |
| Aspira Womens Health | 0.2 | $335k | 103k | 3.25 | |
| Akebia Therapeutics (AKBA) | 0.2 | $288k | 100k | 2.88 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $287k | 20k | 14.35 | |
| Laird Superfood (LSF) | 0.2 | $267k | 14k | 19.07 | |
| Aveo Pharmaceuticals | 0.2 | $247k | 40k | 6.17 | |
| Iveric Bio | 0.2 | $244k | 15k | 16.27 | |
| Irhythm Technologies (IRTC) | 0.2 | $234k | 4.0k | 58.50 | |
| Sientra | 0.2 | $229k | 40k | 5.72 | |
| Arcutis Biotherapeutics (ARQT) | 0.1 | $215k | 9.0k | 23.89 | |
| Inflarx Nv (IFRX) | 0.1 | $181k | 70k | 2.59 | |
| Yield10 Bioscience | 0.1 | $113k | 19k | 6.02 | |
| Therapeuticsmd | 0.1 | $74k | 100k | 0.74 | |
| Concert Pharmaceuticals I equity | 0.0 | $65k | 20k | 3.25 |
